(lp0
S'Teligent, Inc. To Present At Oppenheimer 27th Annual Healthcare Conference On ... Yahoo Finance - Mar 22, 2017 BUENA, N.J., March 22, 2017 /PRNewswire/ -- Teligent, Inc. , a New Jersey based specialty generic pharmaceutical company, will be presenting at the Oppenheimer 27th Annual Healthcare Conference. The Conference is taking place on March 21-22,&nbsp;...'
p1
aS'IGI Laboratories, Inc. Announces Name Change To Teligent, Inc. PR Newswire  - Oct 22, 2015 BUENA, N.J., Oct. 22, 2015 /PRNewswire/ -- IGI Laboratories, Inc. , a New Jersey-based specialty generic pharmaceutical company, announced that it will adopt Teligent, Inc. as its new name and will begin trading under a new symbol - TLGT&nbsp;...'
p2
aS"Teligent, Inc. Announces FDA Approval Of Clobetasol Propionate Gel, 0.05% Yahoo Finance - Mar 8, 2017 BUENA, N.J., March 8, 2017 /PRNewswire/ -- Teligent, Inc. , a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company's abbreviated new drug application  from the U.S.Teligent's  CEO Jason Grenfell-Gardner on Q4 2016 Results - Earnings ... - Seeking Alpha"
p3
aS'Teligent, Inc. Advances $50 Million Facility Expansion PR Newswire  - Jul 6, 2016 BUENA, N.J., July 6, 2016 /PRNewswire/ -- Teligent, Inc. , a New Jersey-based specialty generic pharmaceutical company, recently held the formal groundbreaking ceremony for the ongoing expansion of its manufacturing and research and&nbsp;...'
p4
aS'7.86 MarketWatch - Oct 29, 2015 Teligent Inc. Teligent, Inc. develops, manufactures and markets topical formulations. The company sells generic topical pharmaceutical products under IGI label.'
p5
aS'Teligent, Inc. Announces The Opening Of A Product Development Laboratory In ... PR Newswire  - Oct 11, 2016 TALLINN, Estonia, Oct. 11, 2016 /PRNewswire/ -- Teligent, Inc. , a New Jersey-based specialty generic pharmaceutical company, announced today that it has opened a pharmaceutical Product Development laboratory in Estonia.'
p6
aS'Why Teligent Inc. Plunged 18.5% in February Motley Fool - Mar 7, 2016 26, Teligent won FDA approval for Desoximetasone Ointment USP 0.25%. This approval came only 15 months after the compound being submitted for regulatory approval and the product has an addressable market of approximately $17 million.Generic Topicort Ointment Approved - Pharmacy Times'
p7
aS"Bull Vs. Bear: Teligent, Inc. Motley Fool - May 24, 2016 Brian Feroldi: For several decades, Teligent's stock was a dreadful performer, but that all changed in July 2012 when its current CEO, Jason Grenfell-Gardner, took over and launched the company's TICO strategy."
p8
aS'Teligent, Inc. Announces Fourth Quarter And Year-End 2015 Results PR Newswire  - Mar 9, 2016 Teligent acquired three currently marketed injectable products from Concordia Pharmaceuticals, Inc., S.A.R.L., for $10 million in cash: Fortaz, Zinacef, and Zantac Injection in October 2015.'
p9
aS"Teligent, Inc. Announces FDA Approval Of Triamcinolone Acetonide Ointment USP ... PR Newswire  - May 16, 2016 BUENA, N.J., May 16, 2016 /PRNewswire/ -- Teligent, Inc. , a New Jersey-based specialty generic pharmaceutical company, announced today that it has received approval of the Company's abbreviated new drug application  from the&nbsp;..."
p10
a.